Latest News


Eagles News

The latest news from the Fraternal Order of Eagles

Specify Alternate Text

FOEDRC Continues To Lead In Studies Increasing Our Understanding of FGF21

DRC Director's Report, July 2017

As diabetes researchers work to identify potential new treatments for diabetes, colleagues at the FOEDRC continue to advance our understanding of how newly discovered hormones might work in ways that may lead to new ways to treat and prevent obesity and diabetes. One such hormone is fibroblast growth factor 21 (FGF21). Dr. Matthew Potthoff recently showed in mice that this hormone critically regulates the “sweet tooth” in mice. In a recent follow up study with collaborators from Denmark and published in the Journal Cell Metabolism,  it is now confirmed that FGF21 also regulates sweet preference in humans.  Now, Dr. Potthoff’s team has solved another piece of the puzzle by showing how and where FGF21 might act to regulate the body’s metabolism.

Specify Alternate Text

DRC Receives $2.02 Million Training Grant From National Institutes of Health

I am pleased to share with you that Dr. E. Dale Abel, Director of the Fraternal Order of Eagles Diabetes Research Center (FOEDRC) and Chair of the Department of Internal Medicine, and Dr. Andrew (Andy) Norris, FOEDRC’s Associate Director, have just been awarded a five-year, $2.02M training grant from the National Institutes of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health. The T32 grant will fund the Diabetes Research Training Program at the University of Iowa and will support up to six post-doctoral trainees or subspecialty fellows per year. The grant will support existing trainees or support the recruitment of outstanding new trainees to the University of Iowa.

Specify Alternate Text

Understanding How The Bacteria In Our Gut Affects Diabetes

DRC Director's Report, May 2017

Diabetes significantly increases the risk for heart attacks and stroke. However treating blood sugar levels and even high cholesterol in the blood might not completely prevent these complications of diabetes. For this reason many researchers are looking for new connections between diabetes and vascular disease. FOEDRC researchers Dr. Ajit Vikram and Kaikobad Irani recently published an important discovery in the Journal Nature Communications that provides new understanding of why blood vessel inflammation and damage occurs in subjects at high risk for cardiovascular disease.

Specify Alternate Text

ADA To Honor Career Achievements of Daryl Granner, MD

DRC Director's Report, April 2017

Dr. Daryl Granner is the founding director of the Fraternal Order of Eagles Diabetes Center (FOEDRC). He is a stalwart in diabetes research and I am deeply grateful for the groundwork which he laid in putting in place the structure and framework around which the FOEDRC has been built and for his ongoing commitment to our success. Thus, I was particularly pleased to learn that Dr. Granner will be recipient of one of the most prestigious awards granted for a life-long commitment to diabetes research from the American Diabetes Association.

Specify Alternate Text

How Diabetes Harms The Heart

Study in mice involving FOEDRC researchers, reveals heart-damaging pathway triggered by insulin, identifies possible drug targets to prevent or treat heart failure.

Diabetes is hard on the heart.

Cardiovascular disease is the leading cause of death in people with diabetes, and risk for heart failure—where the heart can’t pump enough blood—is two to three times higher in men and up to five times higher in women with diabetes compared to people without diabetes.

Specify Alternate Text

Adams Named Fraternal Order of Eagles Diabetes Research Chair

Christopher Adams, MD, PhD, has been named the Fraternal Order of Eagles Diabetes Research Chair. This position has been endowed by the Fraternal Order of Eagles (FOE) to propel and accelerate the pace of discoveries in the FOE Diabetes Research Center (FOEDRC), whose mission is to advance knowledge of the mechanisms of diabetes and its related complications through cutting-edge research.

Specify Alternate Text

Happy New Year From The DRC

The FOE Diabetes Research Center at the University of Iowa wishes you a heartfelt Happy New Year! Our ongoing commitment and resolution to the Fraternal Order of Eagles and the entire community is to continue research aimed at bettering the lives of all who live with diabetes and to rigorously search for ways to cure or reverse the alarming increase in diabetes across the world.

Specify Alternate Text

The University of Iowa and FOE DRC Welcome Dr. Ethan Anderson

I am pleased to announce the recruitment of Ethan Anderson, PhD to the FOEDRC.  Dr. Anderson recently joined the Division of Pharmaceutics and Translational Therapeutics within the Department of Pharmaceutical Sciences and Experimental Therapeutics as an Associate Professor in the University of Iowa College of Pharmacy.  Dr. Anderson received his B.S. from the University of Minnesota and PhD from Yale University.  Dr. Anderson’s research is focused on cardiac complications of diabetes, cardiac inflammation and fibrosis, and towards development of novel therapeutics and biomarkers of heart disease risk.

Specify Alternate Text

An M-Health Intervention To Increase Activity Among Patients At Risk For Type 2 Diabetes

In 2013, Dr. Philip Polgreen was the recipient of a FOEDRC Pilot Grant for his research entitled, “To evaluate a novel tool using text messages as a mechanism to promote sustained weight loss in patients with obesity and insulin resistance.” This cutting edge science was recently recognized and awarded additional funding by the National Institutes of Health (NIH).